{"_links":{"self":[{"href":"/inconsultationprojects?Page=0&PageSize=2048"}]},"_embedded":{"nice.indev:inconsultation-product":[{"_links":{"self":[{"href":"/guidance/GID-MT553/consultation/html-content"}]},"ETag":null,"Reference":"GID-MT553","Title":"GID-MT553 Synergo for non-muscle-invasive bladder cancer","ConsultationName":"Draft guidance","StartDate":"2021-06-18T00:00:00","EndDate":"2021-07-16T17:00:00","ConsultationType":"Draft guidance","ResourceTitleId":"html-content","ProjectType":"MTG","ProductTypeName":"Medical technologies guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1229,"Process":"MT","HasDocumentsWhichAllowConsultationComments":true,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-NG10086/consultation/html-content-2"}]},"ETag":null,"Reference":"GID-NG10086","Title":"Tobacco: preventing uptake, promoting quitting and treating dependence (update)","ConsultationName":"Draft guidance consultation","StartDate":"2021-06-25T00:00:00","EndDate":"2021-08-06T17:00:00","ConsultationType":"Draft guidance consultation","ResourceTitleId":"html-content-2","ProjectType":"NG","ProductTypeName":"NICE guideline","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":"PH","RelevantTo":"PH","ConsultationId":1297,"Process":"PHG","HasDocumentsWhichAllowConsultationComments":false,"IsCHTE":false,"AllowedRole":"CfGTeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-NG10123/consultation/html-content-3"}]},"ETag":null,"Reference":"GID-NG10123","Title":"Pelvic floor dysfunction: prevention and non-surgical management","ConsultationName":"Draft guidance consultation","StartDate":"2021-06-28T00:00:00","EndDate":"2021-08-09T17:00:00","ConsultationType":"Draft guidance consultation","ResourceTitleId":"html-content-3","ProjectType":"NG","ProductTypeName":"NICE guideline","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":"CG","RelevantTo":"CG","ConsultationId":1388,"Process":"CG","HasDocumentsWhichAllowConsultationComments":false,"IsCHTE":false,"AllowedRole":"CfGTeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-IPG10169/consultation/html-content"}]},"ETag":null,"Reference":"GID-IPG10169","Title":"Coronary sinus stent insertion for refractory angina","ConsultationName":"Interventional procedure consultation","StartDate":"2021-06-24T00:00:00","EndDate":"2021-07-22T17:00:00","ConsultationType":"Interventional procedure consultation","ResourceTitleId":"html-content","ProjectType":"IPG","ProductTypeName":"Interventional procedures guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1387,"Process":"IP","HasDocumentsWhichAllowConsultationComments":true,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-IPG10168/consultation/html-content"}]},"ETag":null,"Reference":"GID-IPG10168","Title":"Restorative Neurostimulation to Activate the Lumbar Multifidus for chronic mechanical low back pain","ConsultationName":"Interventional procedure consultation","StartDate":"2021-06-24T00:00:00","EndDate":"2021-07-22T17:00:00","ConsultationType":"Interventional procedure consultation","ResourceTitleId":"html-content","ProjectType":"IPG","ProductTypeName":"Interventional procedures guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1386,"Process":"IP","HasDocumentsWhichAllowConsultationComments":true,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-QS10094/consultation/html-content"}]},"ETag":null,"Reference":"GID-QS10094","Title":"Perioperative care","ConsultationName":"Topic engagement","StartDate":"2021-07-13T00:00:00","EndDate":"2021-07-27T17:00:00","ConsultationType":"Topic engagement","ResourceTitleId":"html-content","ProjectType":"QS","ProductTypeName":"Quality standard","ShowExpressionOfInterestSubmissionQuestion":true,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1347,"Process":"QSD","HasDocumentsWhichAllowConsultationComments":false,"IsCHTE":false,"AllowedRole":"HSCTeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-TA10583/consultation/html-content"}]},"ETag":null,"Reference":"GID-TA10583","Title":"Pembrolizumab with chemotherapy and surgery for treating resectable gastric or gastro-oesophageal junction cancer [ID2696]","ConsultationName":"Appraisal consultation","StartDate":"2021-07-01T00:00:00","EndDate":"2021-07-29T17:00:00","ConsultationType":"Appraisal consultation","ResourceTitleId":"html-content","ProjectType":"TA","ProductTypeName":"Technology appraisal guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1392,"Process":"STA 2018","HasDocumentsWhichAllowConsultationComments":false,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-TA10775/consultation/html-content"}]},"ETag":null,"Reference":"GID-TA10775","Title":"Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapy [ID3892]","ConsultationName":"Appraisal consultation","StartDate":"2021-07-05T00:00:00","EndDate":"2021-08-02T17:00:00","ConsultationType":"Appraisal consultation","ResourceTitleId":"html-content","ProjectType":"TA","ProductTypeName":"Technology appraisal guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1396,"Process":"STA 2018","HasDocumentsWhichAllowConsultationComments":false,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-QS10087/consultation/html-content"}]},"ETag":null,"Reference":"GID-QS10087","Title":"Neonatal parenteral nutrition","ConsultationName":"Topic engagement","StartDate":"2021-07-06T00:00:00","EndDate":"2021-07-20T17:00:00","ConsultationType":"Topic engagement","ResourceTitleId":"html-content","ProjectType":"QS","ProductTypeName":"Quality standard","ShowExpressionOfInterestSubmissionQuestion":true,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1345,"Process":"QSD","HasDocumentsWhichAllowConsultationComments":false,"IsCHTE":false,"AllowedRole":"HSCTeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-TA10650/consultation/html-content-2"}]},"ETag":null,"Reference":"GID-TA10650","Title":"Berotralstat for preventing acute attacks of hereditary angioedema [ID1624]","ConsultationName":"Appraisal consultation","StartDate":"2021-07-07T00:00:00","EndDate":"2021-07-28T17:00:00","ConsultationType":"Appraisal consultation","ResourceTitleId":"html-content-2","ProjectType":"TA","ProductTypeName":"Technology appraisal guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1398,"Process":"STA 2018","HasDocumentsWhichAllowConsultationComments":true,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-TA10406/consultation/html-content-2"}]},"ETag":null,"Reference":"GID-TA10406","Title":"Fedratinib for disease-related splenomegaly and symptoms in myelofibrosis [ID1501]","ConsultationName":"Appraisal consultation","StartDate":"2021-07-07T00:00:00","EndDate":"2021-07-28T17:00:00","ConsultationType":"Appraisal consultation","ResourceTitleId":"html-content-2","ProjectType":"TA","ProductTypeName":"Technology appraisal guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1397,"Process":"STA 2018","HasDocumentsWhichAllowConsultationComments":true,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-TA10824/consultation/html-content-2"}]},"ETag":null,"Reference":"GID-TA10824","Title":"Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID3928]","ConsultationName":"Appraisal consultation","StartDate":"2021-07-02T00:00:00","EndDate":"2021-07-30T17:00:00","ConsultationType":"Appraisal consultation","ResourceTitleId":"html-content-2","ProjectType":"TA","ProductTypeName":"Technology appraisal guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1395,"Process":"STA 2018","HasDocumentsWhichAllowConsultationComments":false,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-TA10853/consultation/html-content"}]},"ETag":null,"Reference":"GID-TA10853","Title":"Belimumab for treating lupus nephritis [ID2722]","ConsultationName":"Appraisal consultation","StartDate":"2021-07-06T00:00:00","EndDate":"2021-08-03T17:00:00","ConsultationType":"Appraisal consultation","ResourceTitleId":"html-content","ProjectType":"TA","ProductTypeName":"Technology appraisal guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1400,"Process":"STA 2018","HasDocumentsWhichAllowConsultationComments":false,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-HST10028/consultation/html-content-2"}]},"ETag":null,"Reference":"GID-HST10028","Title":"OTL-200 for treating metachromatic leukodystrophy [ID1666]","ConsultationName":"Evaluation consultation","StartDate":"2021-07-09T00:00:00","EndDate":"2021-07-30T17:00:00","ConsultationType":"Evaluation consultation","ResourceTitleId":"html-content-2","ProjectType":"HST","ProductTypeName":"Highly specialised technology","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1399,"Process":"HST","HasDocumentsWhichAllowConsultationComments":false,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-TA10608/consultation/html-content"}]},"ETag":null,"Reference":"GID-TA10608","Title":"Omburtamab for treating relapsed neuroblastoma  [ID1664]","ConsultationName":"Appraisal consultation","StartDate":"2021-07-12T00:00:00","EndDate":"2021-08-09T17:00:00","ConsultationType":"Appraisal consultation","ResourceTitleId":"html-content","ProjectType":"TA","ProductTypeName":"Technology appraisal guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1404,"Process":"STA 2018","HasDocumentsWhichAllowConsultationComments":false,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-MT559/consultation/html-content"}]},"ETag":null,"Reference":"GID-MT559","Title":"MT539 3C Patch System for treating diabetic foot ulcers","ConsultationName":"Draft guidance","StartDate":"2021-07-13T00:00:00","EndDate":"2021-08-10T17:00:00","ConsultationType":"Draft guidance","ResourceTitleId":"html-content","ProjectType":"MTG","ProductTypeName":"Medical technologies guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1194,"Process":"MT","HasDocumentsWhichAllowConsultationComments":true,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-QS10090/consultation/html-content-2"}]},"ETag":null,"Reference":"GID-QS10090","Title":"Joint replacement (primary): hip, knee and shoulder","ConsultationName":"Topic engagement","StartDate":"2021-07-13T00:00:00","EndDate":"2021-07-27T17:00:00","ConsultationType":"Topic engagement","ResourceTitleId":"html-content-2","ProjectType":"QS","ProductTypeName":"Quality standard","ShowExpressionOfInterestSubmissionQuestion":true,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1343,"Process":"QSD","HasDocumentsWhichAllowConsultationComments":false,"IsCHTE":false,"AllowedRole":"HSCTeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-NG10185/consultation/html-content"}]},"ETag":null,"Reference":"GID-NG10185","Title":"Metastatic spinal cord compression in adults: risk assessment, diagnosis and management","ConsultationName":"Draft scope consultation","StartDate":"2021-06-22T00:00:00","EndDate":"2021-07-20T17:00:00","ConsultationType":"Draft scope consultation","ResourceTitleId":"html-content","ProjectType":"NG","ProductTypeName":"NICE guideline","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":"CG","RelevantTo":"CG","ConsultationId":1373,"Process":"CG","HasDocumentsWhichAllowConsultationComments":true,"IsCHTE":false,"AllowedRole":"CfGTeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-DG10039/consultation/html-content"}]},"ETag":null,"Reference":"GID-DG10039","Title":"SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea","ConsultationName":"Diagnostics consultation","StartDate":"2021-07-14T00:00:00","EndDate":"2021-08-04T17:00:00","ConsultationType":"Diagnostics consultation","ResourceTitleId":"html-content","ProjectType":"DG","ProductTypeName":"Diagnostics guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1031,"Process":"DT","HasDocumentsWhichAllowConsultationComments":true,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]},{"_links":{"self":[{"href":"/guidance/GID-MT554/consultation/html-content"}]},"ETag":null,"Reference":"GID-MT554","Title":"GID-MT554 KardiaMobile for the ambulatory detection of atrial fibrillation","ConsultationName":"Draft guidance: 1","StartDate":"2021-07-15T00:00:00","EndDate":"2021-08-12T17:00:00","ConsultationType":"Draft guidance","ResourceTitleId":"html-content","ProjectType":"MTG","ProductTypeName":"Medical technologies guidance","ShowExpressionOfInterestSubmissionQuestion":false,"DevelopedAs":null,"RelevantTo":null,"ConsultationId":1163,"Process":"MT","HasDocumentsWhichAllowConsultationComments":true,"IsCHTE":true,"AllowedRole":"CHTETeam","FirstConvertedDocumentId":null,"FirstChapterSlugOfFirstConvertedDocument":null,"PartiallyUpdatedProjectReference":null,"OrigProjectReference":null,"AreasOfInterestList":[]}]},"ETag":null,"Page":0,"PageSize":2048,"TotalItems":20}